We observed that the migratory capacity of ER-positive breast cancer cells forced to express Wnt5a increased and the knockdown of Wnt5a led to a decrease in migratory capacity, whereas cell proliferation remained unchanged. The gene discussed is WNT5A; the disease is breast cancer.